2019
DOI: 10.1017/s0033291719001582
|View full text |Cite
|
Sign up to set email alerts
|

Transdiagnostic validity of the MATRICS Consensus Cognitive Battery across the autism-schizophrenia spectrum

Abstract: BackgroundAutism Spectrum Disorder (ASD) and schizophrenia are neurodevelopmental disorders which share substantial overlap in cognitive deficits during adulthood. However, treatment evaluation in ASD and treatment comparisons across ASD and schizophrenia are limited by a dearth of empirical work establishing the validity of a standard cognitive battery across ASD and schizophrenia. Promisingly, the MATRICS Consensus Cognitive Battery (MCCB) has been validated in schizophrenia and encompasses cognitive domains… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
16
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(17 citation statements)
references
References 58 publications
1
16
0
Order By: Relevance
“…Thus, if a child has a diagnosis of ASD and develops schizophrenia later on, clinicians may be less likely to diagnose it (Pina-Camacho, Parellada, & Kyriakopoulos, 2016). A recent study found transdiagnostic validity of the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB) across the autism-schizophrenia spectrum in adults (Kuo, Wojtalik, Mesholam-Gately, Keshavan, & Eack, 2019). The study highlights MCCB's applicability to ASD and supports its utility for standardising treatment evaluations of cognitive outcomes across the autism-schizophrenia spectrum.…”
Section: Discussionmentioning
confidence: 83%
“…Thus, if a child has a diagnosis of ASD and develops schizophrenia later on, clinicians may be less likely to diagnose it (Pina-Camacho, Parellada, & Kyriakopoulos, 2016). A recent study found transdiagnostic validity of the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB) across the autism-schizophrenia spectrum in adults (Kuo, Wojtalik, Mesholam-Gately, Keshavan, & Eack, 2019). The study highlights MCCB's applicability to ASD and supports its utility for standardising treatment evaluations of cognitive outcomes across the autism-schizophrenia spectrum.…”
Section: Discussionmentioning
confidence: 83%
“…First, it might be argued that social cognitive measures could perform differently across clinical groups and that transdiagnostic comparisons are therefore inherently invalid. This is an important point; however, the majority of tasks utilized here have been psychometrically validated in each population (Pinkham et al ., 2016 b ; Morrison et al ., 2019), and two recent studies demonstrate that the Mayer–Salovey–Caruso Emotion Intelligence Test (MSCEIT), a well-known emotion processing assessment, and the MCCB are generalizable across ASD and SCZ with partial measurement invariance and full structural invariance (Kuo et al ., 2019 a , 2019 b ). The parallel nature of the MSCEIT and the assessments used here suggests that our measures are also transdiagnostically valid; however, this should be confirmed in future analyses.…”
Section: Discussionmentioning
confidence: 99%
“…Because the WAIS does not include measures of visual or verbal memory, we were unable to examine cognitive functioning in these domains. Thus, this work may be further expanded upon by using transdiagnostically validated cognitive batteries that include measures of memory, such as the MATRICS Consensus Cognitive Battery (47).…”
Section: Considerationsmentioning
confidence: 99%